{"slideshow_credits": null, "snippet": "Merck agrees to buy Cubist in a deal valued at $9.5 billion. | A hedge fund keeps an S.E.C. inquiry quiet. | Big deals are back this year. | Deal makers regain their power on Wall Street.", "abstract": "Merck agrees to buy Cubist in a deal valued at $9.5 billion. | A hedge fund keeps an S.E.C. inquiry quiet. | Big deals are back this year. | Deal makers regain their power on Wall Street.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "Sydney", "role": "reported", "lastname": "EMBER", "rank": 1, "organization": ""}], "original": "By SYDNEY EMBER"}, "web_url": "http://dealbook.nytimes.com/2014/12/08/morning-agenda-merck-goes-after-cubist/", "lead_paragraph": null, "headline": {"main": "Morning Agenda: Merck Goes After Cubist", "kicker": "DealBook"}, "_id": "5485a57138f0d84e18de0eda", "word_count": "0", "multimedia": [], "pub_date": "2014-12-08T08:17:56Z", "source": "The New York Times", "news_desk": "Business", "keywords": [], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}